BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 18318817)

  • 1. Heparanase and gallbladder cancer: new insights into understanding tumor growth and invasion.
    Dutta U; Poornachandra KS
    J Gastroenterol Hepatol; 2008 Mar; 23(3):343-4. PubMed ID: 18318817
    [No Abstract]   [Full Text] [Related]  

  • 2. Heparanase expression in gallbladder carcinoma and its correlation to prognosis.
    Wu W; Pan C; Yu H; Gong H; Wang Y
    J Gastroenterol Hepatol; 2008 Mar; 23(3):491-7. PubMed ID: 17524042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosquamous/squamous cell carcinoma of the gallbladder.
    Chan KM; Yu MC; Lee WC; Jan YY; Chen MF
    J Surg Oncol; 2007 Feb; 95(2):129-34. PubMed ID: 17262729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of ROR2 and WNT5a expression in squamous/adenosquamous carcinoma and adenocarcinoma of the gallbladder.
    Wu ZC; Xiong L; Wang LX; Miao XY; Liu ZR; Li DQ; Zou Q; Liu KJ; Zhao H; Yang ZL
    World J Gastroenterol; 2017 Apr; 23(14):2601-2612. PubMed ID: 28465645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ILK and PRDX1 are prognostic markers in squamous cell/adenosquamous carcinomas and adenocarcinoma of gallbladder.
    Li J; Yang ZL; Ren X; Zou Q; Yuan Y; Liang L; Chen M; Chen S
    Tumour Biol; 2013 Feb; 34(1):359-68. PubMed ID: 23065574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of clinicopathological significance, FGFBP1, and WISP-2 expression between squamous cell/adenosquamous carcinomas and adenocarcinoma of the gallbladder.
    Yang Z; Yang Z; Zou Q; Yuan Y; Li J; Li D; Liang L; Zeng G; Chen S
    Int J Clin Oncol; 2014 Apr; 19(2):325-35. PubMed ID: 23592278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MUC 1 core protein as a marker of gallbladder malignancy.
    Ghosh M; Kamma H; Kawamoto T; Koike N; Miwa M; Kapoor VK; Krishnani N; Agrawal S; Ohkohchi N; Todoroki T
    Eur J Surg Oncol; 2005 Oct; 31(8):891-6. PubMed ID: 15922536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of primary adenosquamous/squamous cell carcinoma of gallbladder directly invaded duodenum.
    Saito A; Noguchi Y; Doi C; Mukai K; Fukuzawa K; Yoshikawa T; Amano T; Kondo J; Ito T; Izutsu H
    Hepatogastroenterology; 1999; 46(25):204-7. PubMed ID: 10228793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of galectin-3 and Sambucus nigra agglutinin binding site is associated with invasion, metastasis and poor-progression of the gallbladder adenocarcinoma.
    Yang LP; Jiang S; Liu JQ; Miao XY; Yang ZL
    Hepatogastroenterology; 2012 Oct; 59(119):2089-94. PubMed ID: 22497866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of trefoil factor family protein 1 (TFF1, pS2) expression in chronic cholecystitis and gallbladder carcinoma.
    Kornprat P; Rehak P; Lemmerer M; Gogg-Kamerer M; Langner C
    Virchows Arch; 2005 May; 446(5):505-10. PubMed ID: 15821928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant therapy for gallbladder carcinoma: the Mayo Clinic Experience.
    Gold DG; Miller RC; Haddock MG; Gunderson LL; Quevedo F; Donohue JH; Bhatia S; Nagorney DM
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):150-5. PubMed ID: 19297105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosquamous carcinoma of the lung and visceral pleural invasion.
    Riquet M; Assouad J; Le Pimpec-Barthes F; Foucault C
    Ann Thorac Surg; 2004 Oct; 78(4):1511-2; author reply 1512. PubMed ID: 15464536
    [No Abstract]   [Full Text] [Related]  

  • 13. Involvement of heparanase in tumor metastases: a new target in cancer therapy?
    Boyd DD; Nakajima M
    J Natl Cancer Inst; 2004 Aug; 96(16):1194-5. PubMed ID: 15316047
    [No Abstract]   [Full Text] [Related]  

  • 14. Wall-invasion pattern correlates with survival of patients with gallbladder adenocarcinoma.
    Okada K; Kijima H; Imaizumi T; Hirabayashi K; Matsuyama M; Yazawa N; Oida Y; Dowaki S; Tobita K; Ohtani Y; Tanaka M; Inokuchi S; Makuuchi H
    Anticancer Res; 2009 Feb; 29(2):685-91. PubMed ID: 19331223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Outcomes of Adenosquamous Carcinoma of the Gallbladder: an Analysis of the National Cancer Database.
    Murimwa G; Hester C; Mansour JC; Polanco PM; Porembka MR; Wang SC; Zeh HJ; Yopp AC
    J Gastrointest Surg; 2021 Jul; 25(7):1815-1827. PubMed ID: 32705618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gallbladder cancer: a journey of a thousand steps.
    Barreto SG; Dutt A; Sirohi B; Shrikhande SV
    Future Oncol; 2018 Jun; 14(13):1299-1306. PubMed ID: 29722272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor receptor gene amplification is acquired in association with tumor progression of EGFR-mutated lung cancer.
    Yatabe Y; Takahashi T; Mitsudomi T
    Cancer Res; 2008 Apr; 68(7):2106-11. PubMed ID: 18381415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is an adequate extent of resection for T1 gallbladder cancers?
    You DD; Lee HG; Paik KY; Heo JS; Choi SH; Choi DW
    Ann Surg; 2008 May; 247(5):835-8. PubMed ID: 18438121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of hypoxia and re-oxygenation on cell invasion and adhesion in human ovarian carcinoma cells.
    Shi J; Wan Y; Di W
    Oncol Rep; 2008 Oct; 20(4):803-7. PubMed ID: 18813821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic analysis of adenosquamous/squamous cell carcinoma of the gallbladder.
    Kim WS; Jang KT; Choi DW; Choi SH; Heo JS; You DD; Lee HG
    J Surg Oncol; 2011 Mar; 103(3):239-42. PubMed ID: 21337551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.